Inve Guide
Best Stock Research Apps in 2026: Top 10 Compared
If you own individual stocks, the research app we would add first in 2026 is Inve, our own product, and the reason is its Ambition Index: three boards (revenue, margins, capex) with one row per company, where the growth each management is guiding to sits beside the growth the company last filed and the share of this year's guide already in its filings. You can sort companies by the growth they are guiding to and open any row for the quote, so you compare what each management is aiming at before you decide which company to buy. Its Guidance Tracker then keeps score on whether each of those targets is delivered. It costs $9 a month after a free first month. The other nine each win a different job: Koyfin owns customizable macro and cross-asset dashboards, TIKR owns deep global financial statements, Morningstar owns fund ratings, and TradingView owns charts. Two of the ten are desktop websites with no native mobile app at all.
Most rankings of stock research apps treat ten-year income statements, consensus EPS estimates, and AI chat boxes as interchangeable commodities, and ignore the gap that costs stock owners the most: nobody remembers what management said two and four quarters ago. Inve's US record as of 5 September 2026 β 6,132 parsed US earnings calls across 3,157 companies, and 37,529 forward commitments tracked across 885 companies β shows how easily a target drops out of sight. 35.4% of 1,587 tracked tax-related commitments, 31.0% of 882 interest-related commitments (bank net interest income and margin included), and 23.8% of 951 capital-expenditure commitments currently have no spoken close-out on a later call, against 10.1% of 8,270 revenue guides, 9.2% of 2,556 EPS guides, and 9.1% of 3,411 margin guides. Much of that silence is ordinary reporting practice, since tax, interest, and capex figures are usually closed out in 10-Q and 10-K tables; the point is that without a record you cannot tell which is which.
One scope note up front: this list covers fundamental terminals, crowdsourced research communities, charting tools, audio players, and AI-native workflows side by side. Inve is our own product and we earn money when you subscribe to US Pro, so we give the reasons for ranking it first in full and apply the same "where it falls short" audit to it as to the other nine. Our checks of the other tools rest on their public product, pricing, and help pages, plus the third-party reviews named under the table; we did not hold paid TIKR, Fiscal.ai, Koyfin, or Quartr Pro seats, so "we did not find" below means not found in that public material.
The companies and platforms discussed below illustrate an equity research workflow and are not recommendations to buy, sell, or hold any security.
What actually matters in a stock research app
Think of an equity research stack as two very different instruments: a rear-view camera (ten-year statements, valuation multiples, and price charts) and a flight recorder (what executives committed to on past calls, how directly they answered analyst questions, and whether those numbers held up when the quarter closed). Most investors pay three subscriptions for slightly prettier rear-view cameras and keep zero flight recorder.
Five criteria separate a tool worth keeping on your home screen from an expensive distraction:
- Entity and citation verification: Ask any AI research app for a ticker with a near-namesake β SYK is medical-device maker Stryker, not the translation firm Straker β then confirm the issuer name on the source document it cites. An app that cannot show you the source document and a verbatim quote for each figure fails this test.
- Forward guidance you can compare, and memory across quarters: A stock is bought on what the company will do next, yet most tools show only what it already reported. Look for a tool that lines up companies' own forward targets so you can compare them. Summarizing today's 10-Q or earnings call takes thirty seconds anywhere. Remembering that a CFO called a number a "floor" in February, reaffirmed it in April, and cut it 76% in July β across fifteen holdings at once β is the job manual spreadsheets abandon by March.
- Separation of research from trade execution: Brokerages earn commissions or payment for order flow when you trade, and research vendors β Inve included β earn when you subscribe. Keeping your research app separate from the app that executes your trades removes subtle nudges toward over-trading.
- Honest mobile versus desktop ergonomics: Commute workflows β reading a three-minute post-call brief, listening to Q&A, checking whether a new 8-K broke a thesis rule β belong on a phone. Multi-tab valuation modeling and 15-year statement exports still belong on a laptop.
- Price and free-tier honesty: Free tiers in 2026 cover live quotes, 2 to 8 years of statements, and public call briefs. Paid subscriptions only earn their keep when they unlock history, unique KPI disaggregation, or automated monitoring you actually use.
The top 10 stock research apps at a glance
The order below is by job, not by score: we did not run a scored test, so there is no rank column. Inve is our product and we sell US Pro; we placed it first because guidance tracking is the job this article argues most lists leave out, and it is the tool we know best.
| App / Platform | Best for | USD pricing & free tier | Platforms | Key strength |
|---|---|---|---|---|
Inve (inve.money) | Comparing companies' forward guidance on one board (Ambition Index), then tracking whether it is delivered | Free ($0 briefs + 50 calls & 5 ledgers/mo); US Pro: Mo 1 free (no card), then $9/mo or $79/yr | Web, Android (Google Play), Claude & Gemini MCP | Ambition Index: forward revenue, margin & capex guidance compared across companies, backed by 37,529 tracked US guidance rows (as of 5 September 2026) |
| Koyfin | Custom dashboards, macro series & cross-asset charts | Free (2 yrs financials); Plus $39/mo, Premium $79/mo (billed annually; $49/$110 monthly) | Web, iOS & Android | Closest retail workspace to a Bloomberg terminal |
| TIKR | Deep global financial statements & Wall Street estimates | Free (US only, 5 yrs / 8 quarters); Plus $24.95/mo, Pro $54.95/mo | Web only (no native mobile app) | Institutional-grade multi-year statement & estimate depth |
| Fiscal.ai | Company-specific segment KPIs + grounded desktop AI | No free plan (7-day trial); Pro $39/mo billed annually ($49 monthly) | Web only (no native mobile app) | Granular operating KPIs (ARR, store counts, segment units) |
| Seeking Alpha | Crowdsourced bull/bear theses & quant factor grades | Limited free tier; Premium $299/yr | Web, iOS & Android | Deepest library of human bull-versus-bear debates |
| Stock Analysis | Fast, clean free financial statements on web & mobile | Free ( | Web, iOS & Android | Best zero-friction free financial data experience |
| Quartr | Synced earnings-call audio & investor-day slide decks | Free mobile app (iOS/Android); web/desktop = Quartr Pro (sales-led, enterprise) | Web, iOS & Android | Best mobile audio player with slide-by-slide sync |
| Morningstar Investor | Mutual fund, ETF Medalist ratings & conservative Moat research | $34.95/mo or $249/yr (7-day trial) | Web, iOS & Android | Unmatched fund/ETF analyst ratings and portfolio X-ray |
| TradingView | Technical charting, custom scripts & price alerts | Generous free tier; Essential $14.95/mo, Plus $34.95/mo (monthly billing) | Web, Desktop, iOS & Android | World standard for charting across every asset class |
| Simply Wall St | Visual-first company health snapshots for beginners | Free (5 reports/mo); Premium $10.95/mo, Unlimited $21.50/mo (billed annually) | Web, iOS & Android | Fastest one-glance visual summary of balance-sheet health |
Prices checked in November 2026. Confirmed on the vendor's own pages: Inve, Koyfin, TIKR, Seeking Alpha, Stock Analysis, Quartr, Morningstar, TradingView's monthly prices, and Fiscal.ai's prices and 7-day trial (its checkout page). From third-party reviews, not the vendor: Fiscal.ai's history limits per plan (matchmybroker, July 2026; stocksimplifier, September 2026), TradingView's annual-billing prices (costbench, 1 November 2026), and Simply Wall St's US prices (Money Crashers; WallStreetSurvivor, 2026), because its plans page shows local-currency prices outside the US. Prices change β check the vendor's page before you subscribe.
1. Inve β Best for Comparing Forward Guidance Across Companies (Ambition Index)
Inve (US earnings calls hub and Android app on Google Play) is built for investors who own individual stocks and want to know whether management does what it says. It reads SEC 10-K/10-Q statements, Form 4 insider filings, and earnings-call transcripts, and turns the calls into a guidance ledger: every forward target pinned to its period and verbatim quote, then followed across later calls to see what happened.
Why it is first on this list: the Ambition Index. Every other tool here tells you what a company has already reported. The Ambition Index shows what companies say they will do next and sets it against what they have filed. Each company gets one row: the revenue growth it filed last quarter, the growth it is guiding to, and how much of the full-year guide is already in its filings. Sort the board by highest guide and you have a ranked list of who is aiming highest; filter it to companies already growing 20% or more and you see who is aiming high from a strong base. That is the comparison you need when you are choosing between companies to buy, and we did not find it in the public material of the other nine. The Guidance Tracker then follows each target to its outcome. The nearest alternatives for that second job cost several times more: TIKR lists management guidance on its Pro plan at $54.95 a month, and Quartr sells cross-quarter tracking only through its sales-led Pro product. Inve does both for $9 a month, or $79 a year β level with Stock Analysis Pro as the lowest annual price on this list β and the first month is free with no card.
The Ambition Index, board by board
| Board | What each row shows | How you compare |
|---|---|---|
| Revenue | The growth the company filed last quarter, the growth it is guiding to, and how much of the fiscal-year guide is already filed against last year's pace | Sort by highest guide, newest target, or highest last-quarter growth. Filter by whole-company or segment targets, current growth (10%, 20%, 40% and more), and size |
| Margins | Margin targets as percentage levels and basis-point changes | Compared only on the same definition and period, ranked by the size of the change |
| Capex | Each spending plan against the prior year's filed capex, and how much of the year's plan is spent so far | Like-for-like plans ranked by the size of the change |
| Open any row | The last five quarters by segment, segment guides weighted into a company figure, the growth the remaining quarters must deliver, the previous guide when it was raised or cut, and the verbatim quote |
What it does well
- Compare forward guidance across companies (
Ambition Index): The US Ambition Index is three boards (revenue, margins, and capex) with one row per company, each setting what management is guiding to beside what the company has filed; the table above shows what each board gives you. That is the comparison that helps you choose between companies before you buy: who is guiding to faster growth than they just filed, who needs a steep second half to reach the guide, and who has raised or cut. The board does not score companies or say whether they will get there. It is part of US Pro, so it is free for your first month with no card, then included in the $9/month plan. - Cross-quarter guidance reconciliation (
Guidance Tracker): Across 885 US companies and 37,529 tracked commitments (as of 5 September 2026) in the US Guidance Tracker, you see the full arc of what a management said and did on one screen. On Centene, management reaffirmed a full-year 2025 adjusted diluted EPS floor of "greater than $7.25" in February and April 2025, cut the forecast roughly 76% to "approximately $1.75" in July 2025 on Medicaid and Marketplace cost pressure, lifted it to "at least $2.00" in October, and finished the year at $2.08. It then stepped its FY26 floor from "greater than $3.00" to "greater than $3.40", "greater than $4.80" and "greater than $5.20" across 2026. No single-quarter summary shows that pattern; the ledger shows it in one row, with the quote behind each step. Centene is an extreme case β across the US ledger about 28 commitments were marked achieved for every 1 revised down (15,767 against 567, as of 5 September 2026) β and that is the use of the record: the exceptions stand out. - Structured 3-minute call briefs, graded Q&A, and next-quarter watchlists: Every parsed call across 3,157 US companies (as of 5 September 2026) separates executive verdicts, extracted operational KPIs, subsector metrics (software ARR/NDR/RPO, bank NIM/CET1, industrial book-to-bill), and analyst Q&A graded direct / partial / deflected / refused; most calls (84%) add a next-quarter watchlist naming the exact metric, timeline, and quote to monitor.
- Sector earnings boards, Segment Shift, and 24/7
Inve Casemonitoring: Public GICS sector earnings-growth boards track each sector's top 20 companies on a market-cap basis across 12 quarters (membership is point-in-time, so today's top 20 is never projected backwards). US Pro also adds Segment Shift boards (spotting higher-margin divisions outgrowing the core business), and Inve Case β where you define explicit revenue, margin, ROCE, or guidance rules and each new 10-Q, 10-K, and earnings call is checked against them automatically. - Native Claude & Gemini MCP plus $9/month pricing (US pricing): Public US call briefs and stock pages cost $0 with no account required; a free account includes 50 full call reads, 5 guidance ledgers per month, and 1 saved Inve Case. Eligible US/global accounts get one full month of US Pro free (no credit card, no auto-charge), then $9/month or $79/year for 500 call reads, 100 guidance ledgers, Ambition Index, Segment Shift, and 20 Inve Cases β with quotas shared across web, Android, and the Inve for Claude connector (
https://api.inve.money/mcp, also supported on Gemini).
Where it falls short
Know these limits before you subscribe:
- Not a broker. Inve is for research. You place trades in Fidelity, Schwab, Interactive Brokers, or whichever brokerage you already use.
- No iPhone app yet. The native app is Android only. On an iPhone or iPad you read Inve on the mobile web.
- Not a macro terminal or a long-history exporter. It does not cover macro, FX, or bonds the way Koyfin does, and it does not export long-history international statements the way TIKR does.
Verdict: The first paid tool we would add to a stock portfolio, because the Ambition Index lets you compare companies on what they are aiming at, not only on what they have reported. Free call briefs and stock pages cover the basics with no account; US Pro adds the full Guidance Tracker history, the Ambition Index, Segment Shift, and 20 Inve Cases for $9/month ($79/year) after a card-free first month. Pair it with a statements tool such as Stock Analysis and you have both what the company reported and whether management did what it said.
See who is guiding to faster growth than they just filed
Sort US companies by the growth they are guiding to, and open any row for the quote. The Ambition Index is free for your first month with no card, then $9 a month.
Open the Ambition Index2. Koyfin β Best for Custom Dashboards, Macro Context and Multi-Asset Breadth
Koyfin is the closest workspace individual investors and independent RIAs get to a Bloomberg terminal without a five-figure annual contract, spanning global equities, ETFs, mutual funds, Treasury curves, FX, and macroeconomic data across web and native iOS/Android apps.
What it does well
- Cross-asset visualization: Overlay a semiconductor stock's forward EV/EBITDA multiple against SOXX, 10-year real yields, and Capital IQ consensus revenue revisions in a single synchronized chart.
- Polished multi-device experience: Custom market dashboards, earnings calendars, and watchlists carry cleanly from desktop monitors to native iOS and Android apps.
- Clear tiering: Usable free tier (two years of financial history, two watchlists/screens), then Plus at $39/month and Premium at $79/month billed annually ($49 and $110 billed monthly).
Where it falls short
Configuration takes real setup time β Koyfin rewards power users and overwhelms casual check-ins. Two years of financial history on the free tier hits a wall almost immediately for cyclical valuation work, and when we looked in November 2026, transcripts read as documents; we did not find a reconciled commitment-to-outcome ledger.
Verdict: The power user's macro and multi-asset dashboard β worth $39/month (annual) or $49 billed monthly if top-down rates, sector multiples, and consensus revisions drive your process.
3. TIKR β Best for Deep Global Financial Statements and Consensus Estimates
TIKR packages institutional-grade financial statements, multi-year consensus analyst estimates, valuation multiples, and global exchange coverage into a clean, fundamental-first terminal.
What it does well
- Statement history and global breadth: Ten years of standardized income statements, balance sheets, cash flows, and forward street estimates across US and international equities on Plus and Pro (30 years on Ultimate at $119.95/month), at a fraction of legacy terminal pricing.
- Honest pricing for full-time fundamentalists: Free tier covers US stocks only (5 years / 8 quarters of financials); Plus runs $24.95/month and Pro runs $54.95/month (discounted when billed annually).
Where it falls short
TIKR has no native iOS or Android mobile app β its web app is responsive, but navigating wide 10-year financial tables on a phone screen is a pinch-and-zoom chore. Technical charting is minimal, and while transcripts and guidance tables appear on paid tiers, we did not find a view that flags when a prior spoken commitment drops out, so that cross-check stays manual.
Verdict: A benchmark desktop database for deep global statement history β just know before subscribing that it lives in your laptop browser, not as a native phone app.
4. Fiscal.ai β Best for Granular Company-Specific KPIs on Desktop
Fiscal.ai (formerly FinChat) combines standardized financial statements with an unusually deep library of company-specific operating KPIs β streaming subscriber counts, cloud ARR, restaurant store openings, segment unit volumes β paired with a dataset-grounded AI copilot.
What it does well
- Segment and KPI disaggregation: Saves hours of manually typing non-GAAP operating metrics out of quarterly earnings releases, with a 7-day trial and Pro at $39/month billed annually ($49 monthly) for 15 years of financials and 10 years of segment/KPI history (full KPI history needs Max).
- Grounded AI queries: Because the copilot queries Fiscal's structured tables first, numerical answers are far cleaner than ungrounded web-chatbots.
Where it falls short
Like TIKR, Fiscal.ai is web-first with no native mobile app, leaving a gap when results drop while you are away from your desk. Moving up to Max ($79/month annual) pushes close to institutional software budgets, and the copilot answers the prompt you give it; we did not find an automatic quarter-by-quarter audit of open executive commitments.
Verdict: The strongest desktop terminal when unit-level company KPIs (subscribers, backlog, store economics) are the center of your valuation model.
5. Seeking Alpha β Best for Crowdsourced Bull/Bear Theses and Quant Grades
Seeking Alpha hosts one of the largest communities of independent equity contributors online, pairing thousands of long-form bull and bear articles with quantitative factor grades across value, growth, profitability, momentum, and EPS revisions on web, iOS, and Android.
What it does well
- Variant-perception stress testing: On almost any mid-to-large-cap US ticker β even under-covered spin-offs or specialty REITs β you can read three detailed bull theses alongside two skeptical bear cases in twenty minutes.
- Solid native mobile apps: Clean iOS and Android apps for transcripts, dividend safety grades, quant ratings, and portfolio news alerts.
Where it falls short
The paywall arrives fast: the free tier limits how many contributor articles you can read, Premium runs $299/year, and constant upsell banners for Alpha Picks or Investing Groups add friction. Contributor rigor varies from institutional-caliber forensic work to superficial multiple comparisons, so reading critically is mandatory.
Verdict: Unmatched for stress-testing your own thesis against articulate human bulls and bears β budget $299/year and bring your own filter.
6. Stock Analysis β Best Free-First Financial Statements on Web and Mobile
Stock Analysis (stockanalysis.com) executes one job with zero bloat: fast, clean, accurate financial tables, ETF holdings, dividend histories, and screeners across 150,000+ global stocks and funds, backed by lightweight native iOS and Android apps.
What it does well
- Generous zero-login free tier: Roughly five years of annual and quarterly statements, key ratios, analyst forecast summaries, and an intuitive stock/ETF screener at $0 with no account required.
- Low-cost upgrade: Stock Analysis Pro costs ~$79/year ($6.58/month billed annually) for 10+ years of financial history, one Excel/CSV download a day and saved screeners.
Where it falls short
It is a pure data reference table, not an analytical engine β there is no earnings-call Q&A grading, no longitudinal guidance tracking, no valuation modeling workspace, and no automated thesis monitoring.
Verdict: The cleanest free financial-statement lookup on the internet and phone β pair it with Inve ($0 or $9/month) and you cover both historical statements and forward management accountability for a fraction of one legacy terminal.
7. Quartr β Best for Synced Earnings-Call Audio and Slide Decks on Mobile
Quartr turns corporate investor relations into an audio-first mobile experience on iOS, Android, and web, syncing earnings-call recordings directly to searchable transcripts and investor-day slide presentations.
What it does well
- Best commute research habit: Listen to an earnings call at 1.5x speed, tap a Q&A exchange to hear the CFO's exact vocal hesitation, and inspect slide 18 of the earnings deck without downloading three PDFs.
- Free mobile app: Consumer iOS and Android access is $0, while institutional research desks pay for Quartr Pro on desktop.
Where it falls short
The free mobile app is an event player rather than a cross-quarter database: when Chipotle's first Singapore opening slipped from 2026 into early 2027 within two quarters, the app plays each recording cleanly without reconciling prior commitments across quarters. Quartr Pro (sales-led, institutional pricing) is a different product: Quartr advertises AI across company IR material, tracking of changes in messaging and KPIs over time, keyword alerts, and scheduled automations, which overlaps with what Inve does.
Verdict: Install the free mobile app for listening to live and recorded calls on your top holdings; rely on a guidance ledger to verify follow-through.
8. Morningstar Investor β Best for Mutual Fund and ETF Medalist Ratings
Morningstar Investor remains the institutional benchmark for mutual-fund, ETF, and closed-end fund due diligence, combining backward-looking star ratings with forward-looking analyst Medalist ratings and conservative economic-moat equity reports on web, iOS, and Android.
What it does well
- Gold-standard fund and ETF research: Fee analysis, manager tenure, style-box drift, and portfolio overlap ("X-Ray") tools that no stock-only app replicates.
- Disciplined moat and fair-value discipline: Human equity analysts apply consistent wide/narrow/none moat frameworks rather than chasing momentum multiples.
Where it falls short
At $34.95/month or $249/year, Morningstar is expensive if you buy individual stocks rather than funds, its interface feels slower and older than Koyfin or Stock Analysis, and updates follow an editorial library cadence rather than real-time filing parsing.
Verdict: Worth every dollar if ETFs and active funds anchor your retirement accounts; secondary if you run a concentrated individual-stock portfolio.
9. TradingView β Best for Charting, Technicals and Multi-Asset Alerts
TradingView owns technical charting across stocks, indices, futures, FX, and crypto, with fast native apps across web, desktop, iOS, and Android.
What it does well
- Charting and alerting without equal: Hundreds of indicators, Pine Script custom studies, earnings/dividend markers on price bars, server-side alerts, and a generous free tier.
- Reasonable paid ladder: Essential ($14.95/month), Plus ($34.95/month), and Premium ($69.95/month) on monthly billing ($12.95/$29.95/$59.95 billed annually), with steep annual Black Friday and renewal discounts.
Where it falls short
Fundamental statements are basic snapshots β you would never audit segment margin shifts, 10-K footnotes, or management guidance credibility here β and community chart ideas skew heavily toward short-term trading noise.
Verdict: Unbeatable for price structure, relative strength, and entry/exit discipline; pair it with a fundamental tool rather than asking charts to read filings.
10. Simply Wall St β Best Visual Onboarding for Beginners
Simply Wall St translates balance sheets, cash flows, dividend coverage, and insider ownership into standardized visual "snowflake" infographics across web, iOS, and Android.
What it does well
- Zero-jargon visual triage: Beginners can spot excessive leverage, share dilution, or uncovered dividends in thirty seconds without reading raw 10-K tables.
- Modest pricing: Free plan includes 5 company reports/month; Premium ($10.95/month) and Unlimited ($21.50/month) billed annually ($131.40 / $258 a year) unlock broader access.
Where it falls short
Automated visual DCF models and snowflake shapes flatten sector nuances β valuing a bank, a cyclical commodity producer, and a high-RPO software company with one visual template produces frequent false cheap/expensive flags (see our guide to P/E versus EV/EBITDA versus DCF), and you cannot interrogate earnings-call Q&A or guidance revisions.
Verdict: The friendliest visual training wheels for new stock pickers β most investors outgrow it once they start reading primary SEC filings and transcripts.
Which 2-app research stack fits your budget?
Rather than stacking $1,200/year of overlapping data subscriptions, combine one historical statement/chart tool with one forward guidance & filing monitor:
| Investor profile | Recommended stack | Combined cost | Why these tools complement each other |
|---|---|---|---|
| $0 Zero-budget fundamentalist | Stock Analysis (Free) + Inve (Free) + Quartr (Free) | $0 | 5-year clean financials + public US call briefs, GICS sector boards, 50 call reads & 5 guidance ledgers/mo + mobile call audio |
| Serious part-time stock owner (10β20 holdings) | Stock Analysis Free (or Pro $79/yr) + Inve US Pro ($79/yr after free Mo 1) | $79β$158/yr (~$6.58β$13/mo) | 5-year (free) or 10-year+ (Pro) statements + full US Guidance Tracker (37,529 rows as of 5 September 2026), Ambition Index, Segment Shift & 20 automated SEC Inve Cases |
| KPI & valuation modeler at a desk | TIKR Plus ($24.95/mo) or Fiscal.ai Pro ($49/mo) + Inve US Pro ($9/mo), all on monthly billing | ~$34β$58/mo | 10-year global tables / segment KPIs paired with cross-quarter executive commitment tracking & Claude/Gemini MCP |
| Macro + technical + fundamental hybrid | Koyfin Plus ($49/mo) + TradingView Essential ($14.95/mo) + Inve (Free or $9/mo), all on monthly billing | ~$64β$73/mo | Top-down macro & consensus revisions + technical levels + management Q&A and guidance verification |
| Fund and ETF investor | Morningstar Investor ($249/yr), or no subscription at all | $0β$249/yr | Fund ratings, fees, and portfolio overlap are the job |
Check the cost against your portfolio before you pick a row: the top of the hybrid row, about $73/month, is $876/year, a 3.5% yearly hurdle on a $25,000 portfolio. That is why the first two rows cost $0 to $158 a year. Start with the free tiers and Inve's no-card first month before paying for anything.
Compare companies on what they say they will do next
The Ambition Index sets each US company's forward revenue, margin and capex guidance beside what it has filed, one row per company, with the quote behind every line. It is part of US Pro: free for your first month with no card, then $9 a month.
Open the Ambition IndexHow Inve fits alongside Koyfin, TIKR, and Stock Analysis
You do not need to cancel Koyfin, TIKR, or Stock Analysis to add cross-quarter accountability. Our guide to AI workflows for earnings call research and our framework for tracking management guidance across quarters lay out a repeatable four-step quarterly routine:
- Screen and check sector context first: Pull historical statements in Stock Analysis, TIKR, or Koyfin, or filter companies by sector, ROCE, ROE, debt, margins, and growth in Inve's US stock screener, which computes its ratios from SEC filings. Then check Inve's point-in-time US GICS sector earnings boards alongside our guide to reading sector earnings trends during results season to see whether a company's EPS growth actually outperformed its top-20 sector peers or merely floated on an industry tide.
- Look past the consensus "beat": Because Wall Street consensus estimates are routinely walked down before results day β a trap unpacked in why an earnings beat tells you little β open the company's stock page and apply our checklist on how to read an earnings call transcript to focus on Q&A concessions and watchlist items rather than the headline press release.
- Verify prior executive commitments: Check the US Guidance Tracker to compare today's revenue, EPS, margin, and capex guidance against what the same executives guided two and four quarters ago. Then open the Ambition Index to see how that guidance ranks against the other companies you are considering, and Segment Shift for divisional mix changes.
- Automate between-quarter monitoring: Save your falsifiable thesis conditions into an Inve Case (or query your holdings directly inside Claude and Gemini via MCP) so each new 10-Q, 10-K, and earnings call is checked automatically without living inside a brokerage app all week. (If you also invest directly on NSE/BSE, see our companion best stock research apps in India guide.)
Where research app rankings and AI tools can mislead you
The honest counter-case to every tool on this page β Inve included β is that information speed and guidance precision are not investment edge by themselves. A slow-growing incumbent with timid capital allocation can set an easy EPS floor every January, clear it four times in a row, and look spotless inside a guidance ledger while steadily losing market share. Meanwhile, a candid management team investing through a genuine cyclical trough may revise guidance down openly, accumulate missed or revised_down verdicts, and build massive five-year shareholder value.
Four boundaries also apply to every AI and transcript-derived figure cited here:
- Filing conventions versus spoken calls: 35.4% of tracked tax-related guides and 23.8% of tracked capex guides currently have no spoken close-out on a later US call, and those counts include guides not yet due. Much of this is filing convention β figures closed out in 10-Q and 10-K tables rather than hidden. Treating every unspoken close-out as management evasion misreads how US financial reporting works.
- Two-year call window: Inve's US earnings-call archive covers roughly two years of history across 3,157 companies (as of 5 September 2026) β deep enough to audit how an executive team communicates today, nowhere near long enough to judge how it behaves across a full recession.
- Precision over recall: Requiring a verbatim citation before closing a commitment means outcomes that appear only in a filing table, and are never spoken on a later call, stay marked open: the US Guidance Tracker reads earnings calls, not filings. A tool should narrow forty documents down to the three paragraphs you need to read yourself, never replace reading them.
- Machine-generated verdicts: Verdicts and Q&A grades are produced by a language model from the transcript and can be wrong; the verbatim quote is the thing to check.
Before paying for another data terminal, ask one five-year owner's question: when a company I own quietly changes how it defines success three quarters from now, which tool in my stack is actually keeping score?
Frequently asked questions
What is the best stock research app in 2026?
For an investor who owns individual stocks, our pick is Inve (inve.money), our own product. It is the tool on this list built for tracking management guidance across quarters, comparing forward guidance across companies on the Ambition Index (which helps you choose between them before you buy), graded earnings-call Q&A, automated thesis checks against new filings, and Claude/Gemini MCP β starting at $0, with US Pro free for the first month and $9/month or $79/year after. Add one specialist beside it for the job it does not do: Stock Analysis for clean free statements, Koyfin for macro dashboards, TIKR or Fiscal.ai for desktop statement and KPI depth, Morningstar for fund ratings, or TradingView for charts.
What is the Inve Ambition Index?
It is three boards (revenue, margins, and capex) that compare companies' own forward guidance, one row per company. The revenue board sets the growth a company is guiding to beside the growth it filed last quarter, and shows how much of the fiscal-year guide is already in its filings against last year's pace. You can sort it by highest guide, newest target, or highest last-quarter growth, and filter by company size and current growth. Opening a row shows the segment guides, the growth the remaining quarters must deliver, the previous guide when management raised or cut it, and the verbatim quote. It does not score companies or predict whether they will reach the target. You use it to compare companies on what they are aiming at before you choose which to buy. It is part of Inve US Pro: free for the first month with no card, then $9/month or $79/year.
Do TIKR and Fiscal.ai have native mobile apps?
No β both TIKR and Fiscal.ai are web-based platforms without native iOS or Android mobile apps, though their websites work in mobile browsers. Inve offers a native Android app on Google Play alongside its mobile web app and Claude/Gemini MCP connectors (with no native iOS app yet). Koyfin, Seeking Alpha, Stock Analysis, Quartr, Morningstar, TradingView, and Simply Wall St all offer native iOS and Android apps.
What is the best completely free stock research stack in 2026?
Combining Stock Analysis's free app (~5 years of clean financial statements and screeners with no login), Inve's free tier (public US earnings-call briefs, GICS sector earnings boards, plus 50 full call reads, 5 guidance ledgers/month, and 1 automated Inve Case on a free account), and Quartr's free mobile app (synced call audio and slide decks) covers statements, call briefs, and call audio at $0.
How is Inve different from ChatGPT, Claude, or Perplexity for stock research?
General-purpose chat tools search the open web or summarize whatever single PDF you paste in, so the answer is only as good as the documents they happened to find: a wrong issuer, a missing quarter, or a number with no source can pass unnoticed. Ask any tool to show the issuer name on the source document. Inve runs per-document issuer checks across 6,132 US calls and 37,529 tracked commitments (as of 5 September 2026) with verbatim quotes β and exposes that verified database directly to Claude and Gemini via its native MCP server (https://api.inve.money/mcp).
Are paid stock research apps worth $250β$500 a year?
Only when they replace manual work you actually perform. Paying $249/year for Morningstar makes immediate sense if mutual funds and ETFs dominate your portfolio; $299/year for Seeking Alpha pays off if you actively read bull/bear debates on midcaps; and $79/year ($9/month) for Inve US Pro, level with Stock Analysis Pro as the lowest annual price here, unlocks the full Guidance Tracker history, the Ambition Index, 500 call reads, 100 guidance ledgers, and 20 Inve Cases. Measure any subscription against your portfolio β $500/year on a $25,000 portfolio is a 2% yearly hurdle β and use the free tier or no-card trial month before you pay.
What is the difference between a stock research app and a trading app?
Trading apps (Robinhood, Fidelity, Schwab, Interactive Brokers) exist to custody assets and execute orders; research apps exist to help you decide whether to act at all. None of the ten platforms listed here is a brokerage. Keeping research separate from execution is a healthy behavioral guardrail: the app sitting next to a one-tap "Buy" button shouldn't be your sole source of analysis.
Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a qualified financial professional.